Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Experts Welcome Accelerated Approval of Bevacizumab for Breast Cancer
Link ID 3817
Title Experts Welcome Accelerated Approval of Bevacizumab for Breast Cancer
Url http://www.medscape.com/viewarticle/571079?src=rss
Description Bevacizumab has received accelerated approval from the US Food and Drug Administration for use in metastatic breast cancer in combination with paclitaxel chemotherapy. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Mar 7, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Brown to Allow Partial Free Vote on Embryo Law
  Gordon Brown said on Tuesday that Labour MPs will have a free vote on three "ethical" parts of proposed legislation on embryo research after reports said some cabinet ministers could resign over the issue. Reuters Health Information
Category:   Articles > Business of Medicine


2. Merck Agrees to Pay $4.85 Bln in Vioxx Settlement
  Merck & Co has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


3. McCain Assails Democratic Health-Care Approach
  Republican presidential candidate John McCain criticized his Democratic rivals on Monday for a "big government" approach to health care and said he would focus on reducing costs and increasing coverage. Reuters Health Information
Category:   Articles > Business of Medicine


4. VTE Warning for Contraceptive Patch
  The US FDA has updated the labeling for the Ortho Evra patch to include the results of a new study suggesting that it is associated with a higher risk of venous thromboembolism than oral contraceptive pills. Medscape Medical News
Category:   Articles > Business of Medicine


5. Viread Approved for Treating Hepatitis B
  Gilead Sciences Inc said on Monday it won U.S. approval to promote its anti-HIV drug Viread (tenofovir) for treating adults with chronic hepatitis B. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS